Hims & Hers Health Research and Development Expenses 2020-2026 | HIMS

Hims & Hers Health research and development expenses from 2020 to 2026. Research and development expenses can be defined as an expense arising from studies and product development processes.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Hims & Hers Health Annual Research and Development Expenses
(Millions of US $)
2025 $149
2024 $79
2023 $48
2022 $29
2021 $22
2020 $11
2019
2018
Hims & Hers Health Quarterly Research and Development Expenses
(Millions of US $)
2026-03-31 $47
2025-12-31 $41
2025-09-30 $41
2025-06-30 $38
2025-03-31 $30
2024-12-31 $24
2024-09-30 $21
2024-06-30 $19
2024-03-31 $15
2023-12-31 $13
2023-09-30 $12
2023-06-30 $12
2023-03-31 $11
2022-12-31 $8
2022-09-30 $8
2022-06-30 $7
2022-03-31 $6
2021-12-31 $16
2021-09-30 $6
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.429B $2.348B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $24.733B 27.19
Tempus AI (TEM) United States $7.677B 0.00
Doximity (DOCS) United States $3.888B 16.84
IRhythm Holdings (IRTC) United States $3.724B 0.00
10x Genomics (TXG) United States $2.973B 0.00
Privia Health (PRVA) United States $2.810B 131.59
Hinge Health (HNGE) United States $2.789B 0.00
Heartflow (HTFL) United States $2.311B 0.00
Omnicell (OMCL) United States $1.564B 43.00
Inspire Medical Systems (INSP) United States $1.555B 20.94
Enovis (ENOV) United States $1.405B 7.40
Butterfly Network (BFLY) United States $1.047B 0.00
Azenta (AZTA) United States $1.023B 41.13
Clover Health Investments (CLOV) United States $1.013B 0.00
Talkspace (TALK) United States $0.864B 103.40
Schrodinger (SDGR) United States $0.839B 0.00
Phreesia (PHR) United States $0.490B 50.38
Fulgent Genetics (FLGT) United States $0.429B 0.00
Standard BioTools (LAB) United States $0.345B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.322B 0.00
CapsoVision (CV) United States $0.311B 0.00
Senseonics Holdings (SENS) United States $0.279B 0.00
Claritev (CTEV) United States $0.269B 0.00
TruBridge (TBRG) United States $0.268B 8.60
Evolent Health (EVH) United States $0.260B 0.00
Carlsmed (CARL) United States $0.239B 0.00
KORU Medical Systems (KRMD) United States $0.196B 0.00
Zepp Health (ZEPP) Netherlands $0.189B 0.00
CareCloud (CCLD) United States $0.115B 8.18
Nyxoah SA (NYXH) Belgium $0.111B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
American Well (AMWL) United States $0.086B 0.00
Outset Medical (OM) United States $0.077B 0.00
Health Catalyst (HCAT) United States $0.073B 0.00
Pulmonx (LUNG) United States $0.058B 0.00
111 (YI) China $0.057B 0.00
NetraMark Holdings (AINMF) Canada $0.052B 0.00
Precipio (PRPO) United States $0.049B 0.00
HeartBeam (BEAT) United States $0.047B 0.00
Evaxion - (EVAX) Denmark $0.034B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
P3 Health Partners (PIII) United States $0.018B 0.00
EUDA Health Holdings (EUDA) Singapore $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Lunai Bioworks (LNAI) United States $0.009B 0.00
Zhongchao (ZCMD) China $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
PROFUSA (PFSA) United States $0.001B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00